Professor Jason Carroll is a British medical researcher serving as a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge and Founder and Chief Scientific Officer of Azeria Therapeutics. He is a Professor of Molecular Oncology assigned to the Department of Oncology and a Fellow of Clare College, Cambridge.
